Related Experiment Videos
[Focal hemorrhagic chorioiditis (author's transl)]
Klinische Monatsblatter Fur Augenheilkunde
|May 1, 1975
Summary
Focal hemorrhagic chorioiditis is a chronic eye disease with poor visual prognosis. Photocoagulation therapy showed promising results in achieving regression of choroidal proliferations.
Area of Science:
- Ophthalmology
- Medical research
Context:
- Focal hemorrhagic chorioiditis presents a significant challenge in clinical practice.
- Understanding the long-term prognosis and treatment efficacy is crucial for patient care.
Purpose:
- To evaluate the clinical course and visual acuity prognosis of focal hemorrhagic chorioiditis.
- To assess the impact of various treatments, including photocoagulation, on the disease progression.
Summary:
- Clinical and fluorescein angiography follow-up of 111 patients indicated focal hemorrhagic chorioiditis is chronic with poor visual prognosis.
- Half of affected eyes showed inactive scarring after over two years; 13% had bilateral involvement.
- Corticosteroids, antiphlogistics, and vasoactive drugs showed no significant effect.
- Photocoagulation therapy resulted in fast, permanent regression of choroidal proliferations in 15 of 25 treated eyes.
Impact:
- This study highlights the chronic nature and poor visual outcomes associated with focal hemorrhagic chorioiditis.
- Photocoagulation emerges as a potentially effective therapeutic option for managing choroidal proliferations in this condition.